Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Jotin Marango | Chief Financial Officer | 2025-07-28 | 4,630 | $17.16 | $79.45kSell |
David P. Bonita | Director | 2025-07-25 | 83,611 | $29.90 | $2.50MBuy |
Orbimed Advisors LLC | Director | 2025-07-25 | 83,611 | $2.49 | $208.19kBuy |
Otello Stampacchia | Director | 2025-07-25 | 267,556 | $29.90 | $8.00MBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Atlas Venture Life Science Advisors LLC | 124.78% | 5,018,178 | $45.87M | Institution |
Blue Owl Capital Holdings LP | 101.73% | 4,091,118 | $37.39M | Institution |
Bml Capital Management LLC | 100.21% | 4,030,102 | $36.84M | Institution |
Bvf Inc | 99.63% | 4,006,564 | $36.62M | Institution |
Orbimed Advisors LLC | 88.01% | 3,539,358 | $32.35M | Institution |
Jean Francois Formela | 72.15% | 2,901,609 | $26.52M | Insider |
Otello Stampacchia | 67.25% | 2,704,484 | $24.72M | Insider |
Deep Track Capital LP | 62.55% | 2,515,513 | $22.99M | Institution |
Omega Fund Management LLC | 55.93% | 2,249,123 | $20.56M | Institution |
Atlas Venture Fund XI LP | 52.63% | 2,116,569 | $19.35M | Insider |